Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Tillotts Pharma UK Limited., Wellingore Hall, Wellingore, Lincolnshire, LN5 0HX, United Kingdom
Entocort CR 3 mg Capsules.
| Pharmaceutical Form |
|---|
|
Hard gelatin capsules for oral administration with an opaque, light grey body and opaque, pink cap marked CIR 3mg in black radial print. Each capsule contains budesonide 3 mg as gastro-resistant, prolonged-release granules. |
Each capsule contains budesonide 3 mg.
Excipient(s) with known effect: Sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Budesonide |
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
| List of Excipients |
|---|
|
Ethylcellulose |
White polyethylene bottles of 50 or 100 capsules, having either a tamper-evident or child-resistant polypropylene screw cap, with an integral desiccant.
Tillotts Pharma UK Limited., Wellingore Hall, Wellingore, Lincolnshire, LN5 0HX, United Kingdom
PL 36633/0006
Date of first authorisation: 31st January 1996
Date of latest renewal: 4th June 2002
| Drug | Countries | |
|---|---|---|
| ENTOCORT | Austria, Brazil, Canada, Estonia, Finland, France, Hong Kong, Ireland, Malta, Mexico, Netherlands, New Zealand, Poland, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
